JNK-IN-8

Overview

JNK-IN-8 ( JNK Inhibitor XVI) is a potent JNK inhibitor with IC 50 s of 4.7 nM, 18.7 nM, and 1 nM for JNK1 , JNK2 , and JNK3 , respectively.

Application

Products | Products > Disease Areas > Pulmonary Disease | Products > Disease Areas > Depression | Products > Disease Areas > Pain | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Obesity | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Lipid Metabolism | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > JNK

Product Information

• Catalog No.: HY-13319
• CAS No.: 1410880-22-6
• Molecular Formula: C29H29N7O2
• Molecular Weight: 507.59
• Purity: 99.67%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (4.93 mM); Clear solution
• Availability: In-stock

Source

Original product source